Multiple dose levels (1, 4, 8, 12 mg) were tested in Phase 2, with the Phase 3 dose selection to be refined based on efficacy-tolerability balance
Try Greenlight Risk free [email protected] Try Greenlight.
Research shows BPC157 activates pathways related to cell migration, tissue repair, and angiogenesis, supporting angiogenesis research across soft tissues
Disclosure of interest: Jessica Seetge: nothing to disclose, Balzs Cske: nothing to disclose, Zsfia Nozomi Kardi: nothing to disclose, Edit Bosnyk: nothing to disclose, Lszl Szapry: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.02 - LIFE AFTER STROKE P2180 - ESOC25-73 FACTORS ASSOCIATED WITH POST-STROKE MOOD DIFFICULTIES ASSESSED USING THE STROKE IMPACT SCALE-64 IN MULTI-ETHNIC POPULATION Min Sun Kim 1 , L Brian Hickman 2 , Katherine Mun 2 , Nerses Sanossian 3 , Sidney Starkman 2 , Gilda Avila-Rinek 2 , Latisha Sharma 2 , David Liebeskind 2 , Robin Conwit 4 , Scott Hamilton 5 , Jeffrey Saver 1 Brigham and Women's Hospital, Boston, United States, 2 UCLA Medical Center, Los Angeles, United States, 3 USC Medical Center, Los Angeles, United States, 4 National Institute for Neurological Disorders and Stroke, Bethesda, United States, 5 Stanford University, Palo Alto, United States Background and Aims: Studies on predictors of post-stroke mood difficulties have shown inconsistent results, in part due to limitations in mood/depression scales in stroke patients
Asia Pacific Journal of Clinical Nutrition, 17 Suppl 1, 167168
